Unipharma SRL
14.5 FTEUnipharma reported total assets of €2.45m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 14.5 full-time equivalents.
The score of Unipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +2 % Headcount (avg FTE) +34 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Unipharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 91,588 € | ||||
| Equity | 798,860 € | ||||
| Cash | 148,141 € | ||||
| EBITDA | 171,869 € | ||||
| Total assets | €2.45m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 28 Sep 2023
- Year ended 31 Dec 2021filed on 19 Oct 2022
Unipharma's financial analysis
- Solvency32.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Unipharma
Unipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0406.125.637
- VAT number
- BE0406125637
- Peppol
- Registered · 0208:0406125637 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 1969
- Registered office
- 5660 Couvin
- Size
- Small · 14.5 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Unipharma (SRL) has been based in Couvin since 1969, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 91,588 € and equity of 798,860 €; its revenue is not published. With 14.5 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 32.6%, below the median of its sector (41.5%).
Companies similar to Unipharma
Companies in the same business, of comparable size and area, outside its group.
- DE BIE T. Retail sale of pharmaceutical products Affligem · balance sheet €2.45m
- De Witte - De Sutter Retail sale of pharmaceutical products Dendermonde · balance sheet €2.45m
- Abfab Retail sale of pharmaceutical products Anderlecht · balance sheet €2.46m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
- Apotheek VAN DE Mierop - Mestdagh Retail sale of pharmaceutical products Beerse · balance sheet €2.44m
- Tamiphar Retail sale of pharmaceutical products Lasne · balance sheet €2.46m
- Extrapharm HUY Retail sale of pharmaceutical products Huy · balance sheet €2.43m
- Vinvest Retail sale of pharmaceutical products Edegem · balance sheet €2.43m
Frequently asked questions about Unipharma
What is the revenue of Unipharma?
Unipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Unipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0406125637 for Unipharma, if the company is VAT-registered. Its company number (CBE) is 0406.125.637.
Where is the registered office of Unipharma?
According to the CBE register, the registered office of Unipharma is in 5660 Couvin.
What is the equity of Unipharma?
At the close of the 2025 financial year, the equity of Unipharma amounts to 798,860 €, a solvency of 32.6% of total assets.
How many people work at Unipharma?
14.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Unipharma?
The register lists 3 active mandates at Unipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Unipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →